FASN and hepatocellular carcinoma: Although the in vitro anti-proliferative activities of celastrol have been found in multifarious cancer cell lines, the direct targets of celastrol are still complicated.33 Based on the ‘target-precise’ AKT/c-Met HCC model in mice, the suppressing efficiency of celastrol on a novel AKT/FASN cascade is proven.